Moneycontrol PRO
you are here: HomeNewsWockhardt
wockhardt
Jump to
1109 Results Found
  • Wockhardt, Jemincare partner for novel respiratory antibiotic Nafithromycin Aug 26, 2021 02:27 PM IST

    Wockhardt, Jemincare partner for novel respiratory antibiotic Nafithromycin

    Under the terms of the definitive agreement, Jemincare will be responsible for exclusive development and commercialisation of the Nafithromycin in the select markets, Wockhardt said added.

  • Wockhardt share price rises 6% on tie-up with Jemincare for respiratory antibiotic Aug 26, 2021 10:11 AM IST

    Wockhardt share price rises 6% on tie-up with Jemincare for respiratory antibiotic

    Wockhardt will partner with Jemincare for the development and commercialisation of the Nafithromycin in China, Hong Kong, Macau and Taiwan

  • Wockhardt inks pact to produce, supply Sputnik vaccine to Dubai-based firm Aug 13, 2021 12:34 PM IST

    Wockhardt inks pact to produce, supply Sputnik vaccine to Dubai-based firm

    The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF to manufacture and supply Sputnik V, Sputnik Light vaccine against COVID-19, Wockhardt said in a regulatory filing.

  • Wockhardt share price rises 7% on deal to manufacture Sputnik vaccines Aug 13, 2021 12:06 PM IST

    Wockhardt share price rises 7% on deal to manufacture Sputnik vaccines

    The company will manufacture and supply up to 620 million doses of the Sputnik V and the Sputnik Light vaccines

  • Wockhardt Standalone June 2021 Net Sales at Rs 278.95 crore, up 57.08% Y-o-Y Jul 26, 2021 09:22 AM IST

    Wockhardt Standalone June 2021 Net Sales at Rs 278.95 crore, up 57.08% Y-o-Y

  • Wockhardt Consolidated June 2021 Net Sales at Rs 859.55 crore, up 43.67% Y-o-Y Jul 22, 2021 06:13 PM IST

    Wockhardt Consolidated June 2021 Net Sales at Rs 859.55 crore, up 43.67% Y-o-Y

  • Wockhardt Standalone June 2021 Net Sales at Rs 278.95 crore, up 57.08% Y-o-Y Jul 22, 2021 06:06 PM IST

    Wockhardt Standalone June 2021 Net Sales at Rs 278.95 crore, up 57.08% Y-o-Y

  • Wockhardt posts Rs 6.58 crore loss for April-June quarter Jul 22, 2021 04:11 PM IST

    Wockhardt posts Rs 6.58 crore loss for April-June quarter

    The company had posted a net profit of Rs 759.75 crore for the corresponding period of the previous fiscal, Wockhardt said in a filing to BSE stock exchange.

  • Wockhardt Standalone March 2021 Net Sales at Rs 261.75 crore, up 61.36% Y-o-Y May 28, 2021 09:44 AM IST

    Wockhardt Standalone March 2021 Net Sales at Rs 261.75 crore, up 61.36% Y-o-Y

  • Wockhardt Consolidated March 2021 Net Sales at Rs 631.96 crore, down 8% Y-o-Y May 28, 2021 09:33 AM IST

    Wockhardt Consolidated March 2021 Net Sales at Rs 631.96 crore, down 8% Y-o-Y

  • Wockhardt share tanks 16% after a loss of Rs 93 crore in Q4 May 27, 2021 03:56 PM IST

    Wockhardt share tanks 16% after a loss of Rs 93 crore in Q4

    Wockhardt reported a consolidated net loss of Rs 92.8 crore in the March 2021 quarter against a profit of Rs 48.3 crore in the year-ago quarter, dented by the weak US and India businesses.

  • COVID-19 Vaccines | Wockhardt offers to produce 2 billion vaccine doses annually: Report May 26, 2021 09:39 AM IST

    COVID-19 Vaccines | Wockhardt offers to produce 2 billion vaccine doses annually: Report

    A formal submission was made earlier in May and the Centre is “examining the offer”.

  • Wockhardt Hospitals low on COVID-19 vaccines, cannot vaccinate people from April 9 Apr 08, 2021 04:38 PM IST

    Wockhardt Hospitals low on COVID-19 vaccines, cannot vaccinate people from April 9

    Wockhardt is among the nine private vaccination centres that were added by the Mira Bhayandar Municipal Corporation to intensify the inoculation drive in the twin city.

  • Wockhardt Standalone December 2020 Net Sales at Rs 252.97 crore, down 23.05% Y-o-Y Feb 02, 2021 09:22 AM IST

    Wockhardt Standalone December 2020 Net Sales at Rs 252.97 crore, down 23.05% Y-o-Y

  • Rakesh Jhunjhunwala's name appears in Wockhardt's Q3FY21 shareholding pattern; shares jump 6% Jan 20, 2021 01:37 PM IST

    Rakesh Jhunjhunwala's name appears in Wockhardt's Q3FY21 shareholding pattern; shares jump 6%

    It cannot be ascertained if this was the first time when Jhunjhunwala bought a stake in the company or he held any shares of Wockhardt earlier also as companies are not required to publish names of shareholders if their individual holdings are below 1 percent.

  • COVID Vaccine: The opportunities for investors - Part I Dec 11, 2020 08:32 AM IST

    COVID Vaccine: The opportunities for investors - Part I

    Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation

  • Wockhardt Standalone September 2020 Net Sales at Rs 294.96 crore, down 30.48% Y-o-Y Nov 03, 2020 09:22 AM IST

    Wockhardt Standalone September 2020 Net Sales at Rs 294.96 crore, down 30.48% Y-o-Y

  • Wockhardt Consolidated September 2020 Net Sales at Rs 714.05 crore, down 10.99% Y-o-Y Nov 03, 2020 09:11 AM IST

    Wockhardt Consolidated September 2020 Net Sales at Rs 714.05 crore, down 10.99% Y-o-Y

  • Wockhardt Q2 net profit at Rs 3.29 crore Nov 02, 2020 07:46 PM IST

    Wockhardt Q2 net profit at Rs 3.29 crore

    The company had posted a net loss of Rs 94.24 crore for the same period previous fiscal, Wockhardt said in a BSE filing.

  • Dr Reddy’s: Better US prospects to sustain valuations Oct 29, 2020 03:52 PM IST

    Dr Reddy’s: Better US prospects to sustain valuations

    Dr Reddy's US growth prospects have improved after its recent settlement with Bristol Myers Squibb to launch an oncology drug

  • Wockhardt Q1 net profit at Rs 760 crore Aug 29, 2020 05:00 PM IST

    Wockhardt Q1 net profit at Rs 760 crore

    The company had posted a net loss of Rs 36.88 crore for April-June 2019-20, Wockhardt said in a filing to BSE.

  • Wockhardt shares surge 24% in 3 days on deal for COVID-19 vaccine with UK govt Aug 04, 2020 09:47 AM IST

    Wockhardt shares surge 24% in 3 days on deal for COVID-19 vaccine with UK govt

    The agreement is for 30 million doses, which can be expanded to 400 million doses in the UK.

  • Wockhardt partners with UK govt for COVID-19 vaccines Aug 03, 2020 06:00 PM IST

    Wockhardt partners with UK govt for COVID-19 vaccines

    The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of the company based in North Wales, Wockhardt said in a statement.

  • Wockhardt shares hit 10% upper circuit on COVID vaccines tie-up with UK govt Aug 03, 2020 03:44 PM IST

    Wockhardt shares hit 10% upper circuit on COVID vaccines tie-up with UK govt

    The company will fill-finish COVID-19 vaccines at CP Pharmaceuticals, a subsidiary of Wockhardt in Wrexham, North Wales.

  • Dr Reddy’s investment case bolstered by improved margins and product launch guidance Jul 30, 2020 09:19 AM IST

    Dr Reddy’s investment case bolstered by improved margins and product launch guidance

    Key drag for the Dr Reddy's is India business. Compared to its peers, it has a low revenue share in India and that too is majorly in the acute category

Sections
ISO 27001 - BSI Assurance Mark